Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations-Reference-Cited by-同舟云学术

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations

Published:2017-09 Issue:5 Volume:16 Page:592-599
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Sanders Don B.,Solomon George M.,Beckett Valeria V.,West Natalie E.,Daines Cori L.,Heltshe Sonya L.,VanDevanter Donald R.,Spahr Jonathan E.,Gibson Ronald L.,Nick Jerry A.,Marshall Bruce C.,Flume Patrick A.,Goss Christopher H.

Funder

Cystic Fibrosis Foundation Therapeutics

National Institutes of Health

University of Wisconsin-Madison

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference34 articles.

1. Cystic fibrosis pulmonary exacerbations;Ferkol;J Pediatr,2006

2. Predictive 5-year survivorship model of cystic fibrosis;Liou;Am J Epidemiol,2001

3. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis;Konstan;J Pediatr,2007